Abiopharma

Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis

McKesson Corporation - McKesson to Host Investor Day on September 23, 2025

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04

Vivani Medical Appoints Anthony Baldor as Chief Financial Officer

NanoVibronix Inc Notification (NAOV)

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series

DuPont Completes Qnity™ Board of Directors

Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing